Prothena Corporation plc
Overview
Prothena Corporation plc is a biotech company headquartered in Ireland that specializes in discovering and developing novel therapies for neurodegenerative and rare peripheral amyloid diseases. The company's innovative pipeline focuses on protein dysregulation as a key biological pathway for drug development.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Prothena Corporation plc in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Prothena Corporation plc?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.